What does Yappli do?
Yappli provides a no-code mobile-app platform. Companies can build and operate iOS and Android apps without writing most code in-house. The paying customer is the enterprise or operator that runs the app; end users are its shoppers, members, or employees. The product value is ongoing operation — content updates, push notifications, ID and point-card functions, and app-store compatibility support — not just initial launch. Roughly 80% of revenue comes from recurring platform subscriptions, with the rest from implementation and growth support. Once app operations sit inside Yappli’s workflow, switching frictions can rise. The key checks are churn, average monthly subscription fee per logo, and contract-count progression.
What has driven the stock over the past two years?
The stock rose from ¥585 in April 2025 to ¥1,263 in August 2025, a 116% move, then retraced roughly 40%. The rally followed the first dividend and early evidence that the multi-product line could raise contract value. The pullback followed two disclosures: the November 2025 Choose Monster deal, which added goodwill even as FY12/25 guidance rose, and the February 2026 clarification that the FY12/26 tax shield runs out, so FY12/27 net income normalizes closer to operating profit (OP).
01 · THE RALLY Yappli sells a no-code mobile-app platform used by non-developers at retail-apparel chains, restaurant operators, sports teams, and a growing internal-app customer set. In practice, customers are not only buying app creation. They are buying daily app operations inside one system: Apple and Google store-review handling, OS-update compatibility, push notifications, member ID, point-card functions, and content management. Revenue comes in two layers: recurring platform subscriptions at around 80% of sales, plus one-time professional-services support (creation support at signing and growth support after launch) at around 20%. Since 2024, Yappli WebX, Yappli MiniApp, and Yappli MobileOrder have been added on the same ID and content layer, so cross-sell can lift contribution margin. The key checks are contract growth with sub-one-percent gross-revenue churn, lifetime-value-to-customer-acquisition-cost ratio (1Q FY12/26 6.6x, record), and average monthly subscription fee per logo (¥466k 1Q FY12/26, +3.9% YoY). From the post-IPO trough of ¥585 on April 7, 2025, the stock climbed after the May 14 1Q FY12/25 disclosure that included the first dividend declaration (¥6 interim + ¥6 final, ¥12 total — raised to ¥13 with the November 13 revision; FY12/25 actual payout 18.1%). Investors began to treat Yappli as eligible for capital return, not only reinvestment. The move extended through summer as Yappli WebX — launched May 2025, built on the smartLP software assets acquired in October 2024 — gave the multi-product line credibility. The share reached ¥1,263 on August 18, 2025, a 116% move in four months, and forward EV/OP rose to roughly 15x.
02 · THE REVERSAL On November 13, 2025 management did two things in a single disclosure. First, it upward-revised the FY12/25 OP guide from ¥750M to ¥830M and raised the dividend forecast in tandem; read alone, the revision should have extended the climb. Second, a separate release the same day announced the acquisition of Choose Monster for ¥130M cash, of which ¥113M — 87% of the purchase price — was recognized as goodwill amortized over nine years, with no published comparison to the alternative of repurchasing ¥130M of Yappli stock at the then-prevailing valuation. Through autumn the multiple compressed as the market re-priced execution risk on the multi-product pivot. On February 13, 2026 management published FY12/25 actuals — revenue ¥6,056M (below the unchanged ¥6,200M plan), parent OP ¥889M (+61.5% YoY; consolidated ¥882M), net income ¥920M — profit beating the November-raised guide. But the FY12/26 guide framed a slower year (OP ¥1,000M, net income ¥930M flat) and the briefing spelled out a structural point that would weigh on the multiple for six months: the carry-forward losses providing a tax-shield on net income would run out in FY12/26, after which FY12/27 net income would normalize to the OP base. That clarifying comment became the multiple-compression trigger. Investors began discounting an FY12/27 net-income optics drag despite no change in the underlying business, and through spring the share retraced through the ¥800s to the ¥700s. The reversal carried two structural sources: a partly-justifiable compression as the FY12/26 guide implied a slower slope after FY12/25, and a partly-over-extended discount built around the FY12/27 tax-shield narrative.
03 · WHERE WE STAND NOW The 1Q FY12/26 print landed on May 13, 2026: revenue ¥1,707M (+19.1% YoY), OP ¥396M (+77.6% YoY), net income ¥390M (+75.1% YoY), and OP margin at an all-time high of 23.2% — 8.5ppt above the FY12/26 full-year guide of 14.7%. Gross-revenue churn (LTM) improved from 0.92% to 0.86%, ahead of management's prior "2H FY12/26 improvement" timeline. The lifetime-value-to-acquisition-cost ratio climbed to 6.6x, above management's own 5x re-investment threshold. Total contracts rose to 958 across the four-product line, with cross-sell wins at Alpen, Dr. Martens, and Sarutahiko Coffee. Management paired the print with a second upward dividend revision (FY12/26 from ¥14 to ¥15, payout 20.6%); on April 1 it had installed four new executive officers (COO, CFO, CHRO; Chief of Staff from January 1) — the CFO appointment in particular signals capital-allocation discipline will be more institutionalized. The share has eased back to ¥745, still 41% below the August 2025 peak. The implied compression is roughly 6.5x of forward EV/OP, half justifiable and half over-discount: an FY12/26 guide the 1Q print signals is conservative, a ¥1bn-plus net cash pile, a 37% ROE, and a still-undefined capital-return policy. The next four quarters will resolve three things: whether 2Q and 3Q FY12/26 each land at or above 18% OP margin once the planned ¥180M / quarter lead-generation ad-spend resumes; whether the FY12/26 results disclosure in February 2027 formalizes a total-return policy on top of the ¥15 dividend; and whether cohort-level churn disclosure separates the Marketing-cohort story from the HR / UNITE tailwind that has carried the headline.
Which debates are driving the stock now?
Three open questions surface in the company's recent quarterly disclosures and in the IR briefing Q&A. Each one settles a different part of the multiple.
What could change over the next twelve months?
Three disclosure or capital-policy levers drawn from the company's disclosed capital-efficiency blind spots. Each could reweight the multiple without requiring higher earnings.
What has to be true for the stock to work from here?
Three internally-consistent scenarios across the next four quarters. Each describes a different bundle of disclosure and operating outcomes — no single scenario is forecast; they are analytical bookends.
- 2Q FY12/26 OP margin compresses below 16%; full-year lands at the 14.7% guide.
- FY12/26 contract count grows below +5% as the Marketing cohort sees renewed churn pressure (LTM ticks back above 1.0%).
- FY12/26 results retain the existing payout target; no buyback authorization; net cash crosses ¥1.5bn.
- No cohort-level churn disclosure; YFC year-one revenue under ¥250M with operating contribution below break-even.
- FY12/27 net-income normalization narrative dominates the read as the tax-shield runs out.
The bear band of ¥550–¥650 implies ~4.6–5.6x FY12/26 forward EV/OP — meaningfully below the Japanese mid-cap SaaS peer band of 10–15x and below the JP private-buyer 7–10x cohort for asset-light specialty technology businesses. Multiple-driven only if the market discounts the recurring book's durability beyond what a strategic acquirer would pay for it.
- 2Q FY12/26 (Aug 2026) prints OP margin ≥18% with revenue growth ≥15% YoY; FY12/26 OP comes in ≥¥1,080M (8% above guide) on an upward revision filed at 3Q.
- FY12/26 contract count exceeds 1,020 on continued multi-product cross-sell.
- Either a cohort-level churn / NRR breakdown or a formula-based capital-return policy is published at FY12/26 results.
- YFC year-one revenue lands in ¥250–400M band with positive contribution.
- 2Q FY12/26 OP margin ≥20%, revenue growth ≥18%; FY12/26 OP ≥¥1,150M (15% above guide); upward revision filed.
- Total contract count reaches ≥1,050 on Yappli MiniApp + MobileOrder traction beyond the named-account exemplars.
- Capital-return policy is formalized at FY12/26 results with a buyback authorization in the ¥300–500M range alongside the dividend.
- Cohort-level churn disclosed; Marketing cohort confirmed below 1.0% LTM.
- Management pre-frames the FY12/27 net-income transition in the FY12/26 briefing — OP growth ≥15% in FY12/27 with NI optics reset to operating base.
The bull peak of ¥1,350 sits modestly above the August 2025 high of ¥1,263 and embeds a re-rating to ~13-15x forward EV/OP — in the band where Japanese profitable mid-cap SaaS names like Cybozu (10x), PR TIMES (12x), and HENNGE (25x) cluster. Re-rating beyond that requires Yappli WebX and MiniApp turning into second compounding engines, which is multi-year optionality outside the four-quarter scenario.
This is not investment advice.
Japan Investor Interface Co., Ltd. ("JII") is an investor-relations (IR) consultancy. JII is not a registered investment advisor, financial advisor, broker-dealer, or securities firm in any jurisdiction. JII is not registered as a Financial Instruments Business Operator (金融商品取引業者) under Japan's Financial Instruments and Exchange Act. JII does not have a 投資助言・代理業 registration and does not provide investment advice or solicit the purchase, sale, or holding of any security.
JII Compounders is an editorial publication. Each profile is an analytical study of how publicly disclosed information about a Japanese listed company has been received by the market. It is intended for educational and research purposes for IR professionals, finance students, journalists, and other readers interested in corporate disclosure practice. Nothing in this publication constitutes a recommendation, opinion, suggestion, or solicitation to buy, sell, or hold any security, derivative, or other financial instrument. Price targets, scenario ranges, multiples, and comparable-company references are illustrative of analytical method only and must not be interpreted as JII's investment opinion. JII does not have an investment opinion on any security discussed.
No reliance. The information presented may be incomplete, out of date, or incorrect. Forward-looking statements are inherently uncertain. Past price performance does not indicate future results. Estimates and scenario figures are not predictions and may not be achieved. JII makes no representation or warranty, express or implied, regarding the accuracy, completeness, timeliness, or reliability of any information in this publication.
No fiduciary or advisory relationship. Reading this publication does not create any advisory, fiduciary, or professional relationship between you and JII. Before making any investment, tax, accounting, legal, or other decision, you should consult qualified, licensed advisors in your jurisdiction and conduct your own independent due diligence based on primary disclosures issued by the company concerned.
Conflicts & positions. JII may provide paid IR diagnostic, translation, or interpretation services to Japanese listed companies, including companies discussed in this publication. JII does not trade in or hold positions in the securities of companies profiled. Where a JII engagement exists with a profiled company, that fact will be disclosed at the top of the profile.
Trademarks & data. Company names, logos, tickers, and product names referenced are the property of their respective owners. Share-price data is licensed from third-party providers. TradingView is a trademark of TradingView, Inc. All rights reserved.
本資料は、日本の金融商品取引法に基づく投資助言・代理業ではなく、特定の有価証券の売買その他の取引の勧誘・推奨を目的とするものではありません。本資料は教育・研究を目的とした分析記事であり、JII（株式会社ジャパン・インベスター・インターフェース）は、本資料の内容に基づく投資判断について一切の責任を負いません。投資の判断はご自身の責任と独立した調査に基づいて行ってください。